Figure 1.
Genetic profiles of patients with CLL with CDKN2A/B deletion. Bone marrow or peripheral blood analysis at the time of the first CDKN2A/B deletion detection using FISH. Fine and Gray model for RT (n = 20) or prolymphocytic leukemia (n = 1). IGHV, immunoglobulin heavy-chain variable region.